Economic Evaluation of Multiple Sclerosis in the UK, Germany and France

Author： Murphy N.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.5, 1998-05, pp. : 607-622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries: France, Italy, Germany and the UK

By Lafuma Antoine  

PharmacoEconomics, Vol. 24, Iss. 2, 2006-01 ,pp. : 193-205

Adis International

Access to resources Recommend Favorite

Evaluation of brainstem involvement in multiple sclerosis

By Habek Mario  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 3, 2013-03 ,pp. : 299-311

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of mitoxantrone for the treatment of multiple sclerosis

By Jain K.K.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 5, 2000-05 ,pp. : 1139-1149

Informa Healthcare

Access to resources Recommend Favorite

Economic Burden of Multiple Sclerosis: A Systematic Review of the Literature

By Naci Huseyin  

PharmacoEconomics, Vol. 28, Iss. 5, 2010-05 ,pp. : 363-379

Adis International

Access to resources Recommend Favorite

The Economic Cost of Multiple Sclerosis in Sweden in 1994

By Henriksson F.   Jönsson B.  

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 597-606

Adis International

Access to resources Recommend Favorite